Professional Documents
Culture Documents
Abstract
CyberKnife, a novel image-guided radiotherapy that relies upon the physical principle underlying
stereotactic radiosurgery as an alternative method for treating complex or inoperable tumors. The complex
three-dimensional imaging system targets cancer tissue and directs a focused beam of highly concentrated
photons to deform the DNA of tumor cells, thus triggering cell death. Evidence of the CyberKnife therapy
efficacy has pointed towards enhanced outcomes, particularly within recurrent or formerly irradiated cases.
As such, the aim of this essay, focuses on carrying out a mini-systematic review of current data, pertaining to
its underlying physical principle and biological application, its advantages, and limitations. Comprehensive
literature analysis was enacted utilizing several scientific databases, encompassing NCBI, PubMed,
ScienceDirect, ELSEVIER, OpenAthens, SpringerLink, and Google Scholar, with focus on the following
radiosurgery” OR “Non-invasive radiotherapy”. Data was selected and extracted based on the pre-
determined eligibility criteria to limit implicit biases and risk of research misinterpretation. The evaluation of
the CyberKnife has indicated a significant advantage within the high precision capability to target tumors,
minimizing damage to surrounding healthy organ tissue, whilst in real-time tumor detection. Unlike
conventional LINAC methods, leakage of radiation into surrounding healthy structures is significantly lower
when using the CyberKnife. As a result, it constitutes an invaluable technique for stereotactic radiosurgery
and tumor therapy. Nevertheless, it has its limitations, which include prolonged recovery time, insufficient
clinical research and testing, as well as dependence on CT imaging. In spite of that, it still marks a vital
Introduction
The CyberKnife (Figure 1), a non-invasive approach for treating cancer, through image-guided stereotactic
radiosurgery, in which X-ray and optical imaging systems are utilized to track in real-time, the targeted
tissue, in conjunction with accurately calibrated algorithms and the Coordinate Transformation Systems.(19)
Thereafter, a medical linear accelerator would deliver ionizing radiation in the form of X-ray beams, to target
the localized tissue.(18) Thus, relying on the interaction between the ionizing radiation and the tissue to
ablate and thus treat the identified range of tumors and certain non-malignant disorders (such as intracranial
The CyberKnife has proven to be effective for the treatment of small, residual, inoperable, or previously
irradiated tumors. Which can be a suitable alternative to provide palliative treatment for patients who have a
poor prognosis.(27) Therefore, research of the CyberKnife and other forms of stereotactic radiotherapy
posits a crucial aspect of oncological therapeutic development, since the high degree of precision in tumor
therapy and minimal damage toward healthy tissue is a positive step towards reducing the vast impact of
cancer and improving the quality of life of patients during and after the procedure. (7,16)
This topic was selected due to evidence pointing towards improved disease control utilizing the CyberKnife
compared to conventional methods, hence making it an apt medical device for cancer therapy. This essay
will revolve around the physical principle, advantages, and disadvantages underlying the application of the
Information Sources
The primary sources selected for this analysis of the CyberKnife were based on determining an eligibility
criterion which assisted in the selection of scientific literature focused on the fundamental principles
underlying stereotactic radiosurgery and how that relates towards the application of the CyberKnife,
particularly within cancer therapy. Therefore, appropriate keywords and search techniques were utilized to
filter a multitude of research papers, articles, and online books. This was conducted to depict relevant
information in relation to the underlying principle explaining how the CyberKnife operates and its
progression within the medical field. As such, the sources were specifically selected via a meticulous search
across major scientific databases, including NCBI, PubMed, ScienceDirect, ELSEVIER, OpenAthens,
SpringerLink, and Google Scholar. A total of 31 sources were selected for extensive review. The search
period was limited from 2005 to 2023 in order to focus specifically on the recent advances in stereotactic
radiosurgery and the CyberKnife, as well as concentrate on the more recent models of the CyberKnife
Eligibility Criteria
A rigorous set of eligibility criteria were formulated in order to identify the resources that would formulate
the backbone of this essay, whilst maintaining objectivity and a lack of bias within the research. The
PICOTS framework was utilized to supplement the developed inclusion criteria, guaranteeing a well-chosen
source pool.
To begin with, the study characteristics were considered to determine the body of research chosen for this
systematic review. The chosen papers had to be fully accessible articles published in English to prevent
incompletely accessed articles. Certain publication types were excluded, such as surveys, individual case
reports, editorials, reviews, or commentaries, in order to impede the selection of more biased or subjective
papers. Instead, the chosen articles required precise relevance to the investigated therapy.
As such, sources should involve the underlying physical principles, applications within cancer therapy,
development across the different models/years, and advantages or limitations posed compared to
conventional methods. Hence creating a more cohesive structure and systematic flow, since the information
collected is directly associated to the essay’s focus. The population of studies also concentrated on the effect
of the CyberKnife treatment on adult patients with malignant tumors. An additional governing factor for the
research on the general application of the CyberKnife treatment focused on cancer, while ruling out papers
A time-based requirement was also included within the exclusion criteria, whereby, resources analyzed must
have been published between 2005 to 2023. Thus, emphasizing the latest models of CyberKnife treatment
and reflecting up-to-date outcomes and trends within the field of stereotactic radiosurgery, upholding the
pertinence of this essay, whilst having a representative sample size for sufficient data collection. Moreover,
the selection necessitated the collection of resources from reputable databases, peer-reviewed journals, and
renowned publications, to ensure that the articles chosen had already undergone rigorous evaluation prior to
publishing, thereby validating the reliability of the references utilized. Within large scientific and medical
databases, the main keywords identified for the search consisted of: “CyberKnife” AND “Oncological
Papers were filtered in order of relevance using the major prior mentioned databases. After narrowing down
the list of resources, abstract screening was conducted to further narrow the focus on the necessary
Results
Physical Principles
The CyberKnife consists of two primary aspects, the 6-MV linear accelerator and the real-time imaging
system. The latter is contingent upon orthogonally arranged X-ray cameras, which capture in real-time
radiographs necessary for tumor targeting to compare to digitally recreated radiograph (DDR) cross sections
derived from the CT scan.(23) By positioning the digital radiograph to match the X-ray image, through
rotation or translation, the CyberKnife imaging software would orient itself to the location of the tumor.(19)
Utilizing the algorithm allows for continuous alignment between the imaging system and the patient, by
determining slight alterations within target position in less than a second with an uncertainty of ±0.5 mm.
This capability is exemplified within Figure 2. The robotic arm moves the linear accelerator within six
degrees of freedom (in the x, y, z planes) following the principle of stereotaxy for accurate tumor targeting,
Thereafter, the ionizing radiation is focused on the targeted tumor consisting of therapeutic X-rays, within
the energy range of higher than 105 eV.(29) After supplying the modulator with DC current, microseconds
long high-voltage pulses are generated. Within the diode-type electron gun, the temperature of the
conducting material (such as tungsten filament) will be increased, thereby producing electrons via
thermionic emission. Afterwards, the released electrons will be pulse-injected and accelerated along the
The magnetron within LINAC systems releases radio frequencies ranging from 30-kHz to 300-GHz. This
triggers microwave pulses through a high-power oscillator. The waveguide contains copper irises between
each cell, enabling electrons to travel along the waveguide and to assist in focusing the beam. To prevent
interference of the electron beam with other particles, a vacuum is created within the electron gun. This
electron beam is controlled by applying the effect of a magnetic field on electron movement. Utilizing two
sets of steering coils, and two sets of focusing coils, the electron beam is controlled and further focused into
a fine point, using the principle where the force direction applied on an accelerated path of electrons is at a
90° angle to the magnetic field and electron motion direction; according to the magnetic force and a moving
electrons are accelerated within the LINAC system, they collide with a small tungsten or gold target,
generating high energy photons or X-rays. The deflection of the electrons as they move near a nucleus,
resultant from Coulomb attraction forces, compels the electrons to lose energy in the form of bremsstrahlung
radiation, generating X-rays in all directions. (3,29) This is modeled by the equation:
The higher the atomic number of the targeted material, the larger the number of X-rays produced. Using a
primary collimator (comprised of tungsten), only forward-traveling X-rays are selected to pass through
producing a cone-shaped beam. The primary collimator plays an essential role in minimizing leakage of
radiation by absorbing scattered lateral X-rays. A flattening filter is applied where, the central part attenuates
more photons than the sides, generating a uniform distribution of photon beams. The shapes are further sub-
specialized via a multileaf collimator in order to best match the conformation of the tumor. As such the
The Guided Image System comprises of two ceiling-mounted X-ray sources and image detectors aligned
perpendicularly.(6) The System detects key structures within space, such as the skull, spine or implanted
gold markers called fiducial markers (FMs), which are small radiopaque objects that remain in constant
position post-implantation and are relative in space to both targeted and normal tissue. The Coordinate
System is defined by the positioning of the FMs, enabling the tumor to be targeted with minimal risk of
normal tissue irradiation. FMs must be synthesized from biologically inert metals, such as gold, that have
large atomic numbers for better visibility on X-ray images.(17) These captured X-ray images are then
compared with the DDR X-ray images, where the difference in the positioning of the patient is calculated.
The X-ray image produced by the CT scan relies on the different attenuations of tissues, dependent upon the
differing atomic numbers within the tissue, characterizing the varying shades in the CT image. As such,
when X-rays are propagated through the sample tissue, some of the photons are absorbed, whilst other
attenuation of X-rays within inhomogeneous material like the human body.(5). Tumor tissue movement is
tracked within respiratory compensation using the image detection system that works in junction with the
optical markers attached to the synchrony vest worn by the patient, and delivers data on the tumor
positioning matching the patient breathing and movement.(6) This application of the CyberKnife imaging
Figure 6:
Example of
Imaging and
Tumor Targeting
for Meningioma
(Shepard)
Within the Stereotactic Body Radiation Therapy (SBRT), a considerable dose of ionizing radiation is
focused at the targeted tumor tissue. Interactions between the X-ray beam and human body occur at both a
cellular and atomic level. Photons in Radiosurgery interact with matter in three primary manners consisting
of photoelectric absorption, Compton scattering (the most significant within radiotherapy), and pair
production. Accordingly, when exploring the effect of photons on human tissue, it is important to focus on
the effect on the individual atoms. Starting with the photoelectric effect, when a photon is absorbed by an
inner shell electron, it gives the electron sufficient energy to be ejected from the atom, most commonly for
the photon energy range up to 0.5 MeV. However, it must be noted that this is not considerably significant
within radiosurgery. As for Compton scattering, when a photon interacts with an electron, its energy is
absorbed, ejecting it from its orbit. Since the Compton scattering is dominant in the range between 200 keV
to 10 MeV, it is the most important interaction in medical applications, including imaging and radiotherapy.
Lastly, within Pair production, a photon transitions into an electron-positron pair, occurring mainly for
These highly focused X-ray beams damage the DNA, proteins and lipids of tumor cells via the stimulation of
free radicals and result in apoptosis, mitotic death, or permanently halting the growth of existing tumor
tissue. This phenomenon is observed within ablative treatment of complex spinal metastatic tumors, as an
example. Whereby, recent evidence expands upon the radiobiological effect of DNA damage, and includes:
tumor necrosis through vascular damage and antitumor immunity. Regional micrometasteses are expunged
and metastatic growth is suppressed through the “abscopal effect”. By altering the microenvironment
beams dictate the penetration depth, whilst the dose affects the pathophysiology of the cancerous tissue, as
witnessed in Figure 11. So, an increase in the concentration of ionizing radiation deposited within the tumor,
improves the CyberKnife therapy effectiveness. This is witnessed within the technique of hypofractionated
irradiation that directly damages the DNA double-strand (killing cells), and degrades the intratumor
microenvironment via microvascular deterioration and endothelial apoptosis causing tumor cell death.(1,7)
Advantages
The CyberKnife has a multitude of advantages that give it an edge over conventional therapies for cancer
and other forms of stereotactic radiosurgery systems. In contrast to other forms of LINAC-based
radiotherapy, which have an accuracy range within millimeters, the CyberKnife accuracy range for tracking
tumor positions is within sub-millimeters. Therefore, if the accuracy of the pinpointed tumor is not
determined to be within a sub-millimeter range, a warning is given, and treatment is stopped. Consequently,
this aids in minimizing the risk of irradiating surrounding healthy tissue and enhances the accuracy of tumor
treatment. This accuracy is further verified by taking orthogonal X-ray images prior to each beam.
Furthermore, the high degree of precision targeting of tumors is maintained by the usage of the stereotactic
frame that determines the exact three-dimensional coordinates of the tumor, delivering the radiation exactly
toward the targeted area. This results in giving an edge towards CyberKnife over other conventional
therapies such as total body irradiation. The precision of the device is further fine-tuned by affixing small
circular collimators at the treatment head, further narrowing the X-ray beam compared to conventional
LINAC systems.(4,16,21)
Another irrefutable advantage of the CyberKnife is the flexibility of the robotic arm, where the arm’s six-
degrees of freedom enables the treatment of tumors across the body with a precise spatial awareness. As
such, in conjunction with the frameless robotic system, a consistent and controlled distribution of radiation
dose may be provided by the beams towards radiation-sensitive locations (e.g., tumors, irregular lesions,
etc.). As well as the application of real-time imaging and smart coordinate system, that further assists in real-
time organ positioning and optimization of radiation doses in contrast to other techniques.(4,16,21)
Certain treatment paths may use a non-isocentric approach and are the most appropriate treatment for
irregularly shaped large tumors and lesions. Accordingly, the CyberKnife solves the geometrical and
invasive limitations associated with frame-based stereotactic and gantry systems. Within the latter, CT
imaging was limited within the head, whilst in the former magnetic resonance systems were not initially
applied within the body. Since the CyberKnife is a minimally invasive procedure, patients experience less
complications associated with surgery, since surgical trauma is eliminated, reducing swelling, tissue loss and
preventing post-op infection. Mortality risks associated with anesthesia are also eliminated. Even then,
inoperable tumors that were not completely resected during surgery, can be terminated or reduced via
CyberKnife treatment. Accordingly, the numerous advantages of CyberKnife therapy indicate its high degree
of versatility and efficacy within the field of stereotactic radiosurgery and non-invasive cancer therapy.
(4,16,21)
Disadvantages
In spite of the numerous advantages of the CyberKnife, it has few limitations. To begin with, the use of
hypofractionation that involves using larger fraction sizes than 8Gy, which, although participates in complete
tumor elimination and risk reduction of the tumor returning. Unfortunately, it also affects the high precision
usually associated with the CyberKnife, damages surrounding healthy tissue, and can also elevate risks of
late toxicity. This is due to the characteristic principle behind CyberKnife of “dose painting” requiring
smaller and more precise volumes. This disadvantage is supported by contemporary studies, in which
evidence suggests that large radiation doses from CyberKnife instigate endothelial cell damage and
contribute to microvascular dysfunction. Tumor cells that experience a low alpha/beta value correlate to an
improved benefit within the treatment. However, the same cannot be said regarding normal healthy tissue.
Whereby, such tissue experiencing the same lower alpha/beta ratio contribute towards injury, when exposed
Moreover, another significant limitation is the protracted treatment time ranging from thirty to sixty minutes.
Even then, the first indications of positive developments are also significantly prolonged, lasting up to 2-3
months post-irradiation, meaning that a patient must wait a lengthy duration for manifestations of treatment
efficacy. This recovery time can last even longer in other types of tumors. According to a study of patients
with prostate cancer who underwent CyberKnife therapy, radiation will remain with shifting levels of PSA
and indefinite tumor results, which could take months to years to fully disappear or could persist in the body
with halted growth. However, this uncertainty and worry can take a toll on the patient's well-being. The
requirement for repeated CT-scans is also a disadvantage as it gives out an extra dose of radiation that the
patient has to be subjected to. Additionally, clinical evidence is still insufficient, meaning that data on the
optimal dose-fractionation as well as optimal Planning Target Volume remain unknown. More clinical
studies are required to optimally decide the dose-fractionation and to more accurately set PTVs.
Consequently, in spite of CyberKnife’s numerous advantages, its limitations must be rigorously investigated
Conclusion
To conclude, CyberKnife signifies a vital and encouraging future within the field of non-invasive
oncological treatment. Within this essay, the foundational physical principles underlying the CyberKnife and
Stereotactic radiosurgery were explored, focusing on the interactions between the photons and the biological
tissue, and how the imaging devices work in conjunction with the linear accelerator to specifically target
cancer, with minimal impact towards surrounding tissue, thus signifying it as an essential developing
standard within cancer management, particularly of difficult to operate/inoperable tumors. The advantages of
CyberKnife therapy were explored, such as the high degree of accuracy, which enables tumor pinpointing
with minimal healthy tissue damage, that is aided via the high degree of freedom within the robotic arm. In
addition, to the real-time positioning and monitoring of patient and tumor movement, for better tumor
targeting. Nevertheless, there were certain disadvantages that affected the efficacy of its application, for
instance, prolonged treatment times, and late manifestations, as well as unknown optimal dose-fractionation
and PTV. In spite of that, these disadvantages may be addressed by promoting increased clinical studies that
could contribute to enhancing understanding of core characteristics within CyberKnife therapy, and gather
more established trends regarding the impact of CyberKnife on different healthy and diseased tissue, to
References
1.Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW. Biological response of cancer cells to radiation treatment. Frontiers in Molecular
Biosciences [Internet]. 2014 Nov 17 [cited 2023 Dec 18];1(24). Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429645/
2.Bibault JE, Prevost B, Dansin E, Mirabel X, Lacornerie T, Lartigau E. Image-Guided Robotic Stereotactic Radiation Therapy with
Fiducial-Free Tumor Tracking for Lung Cancer. Radiation Oncology [Internet]. 2012 Jun 24 [cited 2023 Dec 18];7(1). Available
from: https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-7-102
3.Coste-Manière È, Olender D, Kilby W, Schulz RA. Robotic whole body stereotactic radiosurgery: clinical advantages of the
Cyberknife® integrated system. The International Journal of Medical Robotics and Computer Assisted Surgery [Internet]. 2005 Jan
4.Council R. X-Ray Computed Tomography [Internet]. Nih.gov. National Academies Press (US); 2023 [cited 2023 Dec 19].
%20100%20ms%20per%20slice.
5.CyberKnife Equipment Specifications [Internet]. 1310 Chesapeake Terrace Sunnyvale, CA 94089 USA: Accuray Incorporated;
6.CyberKnife - How it Works | CyberKnife [Internet]. CyberKnife. Accuray Incorporated; 2020 [cited 2023 Dec 18]. Available from:
https://cyberknife.com/cyberknife-how-it-works/
7.Cyberknife - an overview | ScienceDirect Topics [Internet]. sciencedirect. Elsevier; [cited 2023 Dec 18]. Available from:
https://www.sciencedirect.com/topics/medicine-and-dentistry/cyberknife
8.CyberKnife Radiosurgery | Brain Tumor Center [Internet]. braintumorcenter.ucsf.edu. UCSF; 2022 [cited 2023 Dec 18]. Available
from: https://braintumorcenter.ucsf.edu/treatment/radiation-therapy/cyberknife-radiosurgery
9.De Maria L, Terzi di Bergamo L, Conti A, Hayashi K, Pinzi V, Murai T, et al. CyberKnife for Recurrent Malignant Gliomas: A
Systematic Review and Meta-Analysis. Frontiers in Oncology [Internet]. 2021 Mar 29 [cited 2023 Dec 18];11. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039376/
10.Ding C, Saw CB, Timmerman RD. Cyberknife stereotactic radiosurgery and radiation therapy treatment planning system. Medical
Dosimetry [Internet]. 2018 [cited 2023 Dec 18];43(2):129–40. Available from: https://pubmed.ncbi.nlm.nih.gov/29605528/
11.Delaby N, Bellec J, Bouvier J, Jouyaux F, Perdrieux M, Castelli J, et al. CyberKnife® M6TM: Peripheral dose evaluation for
brain treatments. Physica Medica [Internet]. 2017 May [cited 2021 Jul 7];37:88–96. Available from:
https://www.sciencedirect.com/science/article/pii/S1120179717301011
12.Hiroshi Hamakawa, Takahashi Y, Ichiro Sakanoue, Tsunemasa Saitō, Date N, Keisuke Tomii, et al. Salvage Pulmonary
Operations Following Stereotactic Body Radiotherapy for Small Primary and Metastatic Lung Tumors: Evaluation of the Operative
Procedures. Technology in Cancer Research & Treatment [Internet]. 2018 Jan 1 [cited 2023 Dec 18];17:153303381880743-
13.Ihnát P, Skácelíková E, Tesař M, Penka I. Stereotactic body radiotherapy using the CyberKnife® system in the treatment of
patients with liver metastases: state of the art. OncoTargets and Therapy [Internet]. 2018 Aug 1 [cited 2023 Dec 18];Volume
14.Joseph B, Supe SS, Ramachandra A. Cyberknife: A double edged sword? Reports of Practical Oncology & Radiotherapy
[Internet]. 2010 Jul [cited 2023 Dec 18];15(4):93–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863292/
15.Kandola A. What is CyberKnife and how can it help with prostate cancer? [Internet]. Walton A, editor.
https://www.medicalnewstoday.com/articles/cyberknife-for-prostate-cancer#candidates
16.Kataria T, Pushpa Naga Ch, Banerjee S, Gupta D, Narang K, Manoj Tayal, et al. CyberKnife Stereotactic Ablative Radiotherapy
for Recurrent or Oligometastatic Gynecological Cancers. South Asian Journal of Cancer [Internet]. 2021 Apr 1 [cited 2023 Dec 18];
17.Khankan A. Demystifying CyberKnife Stereotactic Body Radiation Therapy for Interventional Radiologists. The Arab Journal of
Interventional Radiology [Internet]. 2021 Apr 10 [cited 2023 Dec 18];1(2). Available from:
https://www.thieme-connect.com/products/ejournals/pdf/10.4103/AJIR.AJIR_19_17.pdf
18.Kilby W, Naylor M, Dooley JR, Maurer CR, Sayeh S. 2 - A Technical Overview of the CyberKnife System [Internet]. Abedin-
Nasab MH, editor. ScienceDirect. Elsevier; 2020 [cited 2023 Dec 18]. p. 15–38. Available from:
https://www.sciencedirect.com/science/article/abs/pii/B9780128142455000025
19.Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer CR. The CyberKnife® Robotic Radiosurgery System in 2010. Technology in
Cancer Research & Treatment [Internet]. 2010 Oct [cited 2023 Dec 18];9(5):433–52. Available from:
https://journals.sagepub.com/doi/pdf/10.1177/153303461000900502
20.Ki Mun Kang, Bae Kwon Jeong, Choi H, Seung Hoon Yoo, Hwang U, Young Kyung Lim, et al. Combination effects of tissue
heterogeneity and geometric targeting error in stereotactic body radiotherapy for lung cancer using CyberKnife. Journal of Applied
Clinical Medical Physics [Internet]. 2015 Sep 1 [cited 2023 Dec 18];16(5):193–204. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690167/
22.Kurup G. CyberKnife: A new paradigm in radiotherapy. Journal of Medical Physics [Internet]. 2010 [cited 2023 Dec
23.Sergej Telentschak, Rueß D, Grau S, Goldbrunner R, Niklas von Spreckelsen, Karolina Jabłońska, et al. Cyberknife®
hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases. Journal of Cancer Research and
Clinical Oncology [Internet]. 2021 Feb 26 [cited 2023 Dec 18];147(9):2765–73. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310836/
24.Sinha S, Reddy ES, Chandra S, Chandra S. CyberKnife radiosurgery: Precision without incision. Journal of Indian Academy of
Oral Medicine and Radiology [Internet]. 2015 [cited 2023 Dec 18];27(1):72. Available from:
https://journals.lww.com/aomr/fulltext/2015/27010/cyberknife_radiosurgery__precision_without.16.aspx
25.Sio TT, Jang S, Lee SW, Curran B, Pyakuryal AP, Sternick ES. Comparing gamma knife and cyberknife in patients with brain
metastases. Journal of Applied Clinical Medical Physics [Internet]. 2014 Jan 6 [cited 2023 Dec 18];15(1):4095. Available from:
https://pubmed.ncbi.nlm.nih.gov/24423830/
26.Soman C, Alghamdi SRM, Alazemi FNM, Alghamdi AAA. Cyberknife Radiosurgery for the Treatment of Head and Neck
27.Tong AN, Yan P, Yuan GH, Lv XY, Gong H, Zhao H, et al. Advantages of CyberKnife for inoperable stage I peripheral non-
small-cell lung cancer compared to three-dimensional conformal radiotherapy. Molecular and Clinical Oncology [Internet]. 2015
28.UFO Themes. The Physics of Stereotactic Radiosurgery [Internet]. Radiology Key. 2017 [cited 2023 Dec 18]. Available from:
https://radiologykey.com/the-physics-of-stereotactic-radiosurgery/
29.What Is Stereotactic Radiosurgery, and What Conditions Does It Treat? [Internet]. Aans.org. American Association of
Stereotactic-Radiosurgery
30.Wowra B, Muacevic A, Tonn JC. CyberKnife radiosurgery for brain metastases. Progress in Neurological Surgery [Internet].